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Abstract 
Purpose: The inflammatory state of adipose tissue in obese subjects 
may be the most important factor linking increased adipose tissue 
mass to insulin resistance. Chemerin is a newly discovered 
adipokine that plays an important role in macrophage infiltration 
into adipose tissue and may contribute to the development of 
inflammation and insulin resistance. We examined the effects of 12 
weeks of aerobic training on serum chemerin levels in association 
with cardiovascular risk factors in overweight and obese males.   
Methods: Twenty-one overweight and obese subjects [44.3 (±4.1 yrs, 
body mass index (BMI) ≥25 kg/m
2) were assigned to exercise 
training (obese EX, n= 11) and control (obese CON, n= 10) groups. 
The obese EX group participated in 12 weeks of progressive 
aerobic training 5 days a week. Serum chemerin, insulin resistance, 
lipid profiles, blood pressure, and body composition were all 
measured before and after the training. 
Results: After the aerobic training, waist circumference (P=0.009), 
fat percent (P=0.03), visceral fat (P=0.03), subcutaneous fat 
(P=0.01), fasting glucose (P=0.01), insulin resistance (P=0.03), 
triglyceride (P=0.05), total cholesterol (P=0.04), low-density 
lipoprotein cholesterol (P=0.05) and systolic blood pressure 
(P=0.04) of participates were significantly decreased. Concurrently, 
serum chemerin concentrations were significantly decreased after 
aerobic program (P=0.02).  
Conclusion: Aerobic training caused an improvement in cardio-
metabolic risk factors in obese subjects, and this improvement was 
accompanied by decreased chemerin levels. 
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INTRODUCTION 
besity, particularly visceral adiposity, is 
accompanied by chronic low-grade inflammation, 
indicated by increased serum levels of inflammatory 
markers such as C-reactive protein (CRP), tumor 
necrosis factor-α (TNF-α), and interleukin-6 (IL-6) of 
obese patients
[1,2]. Chronic inflammation is a well-
known risk factor of insulin resistance and metabolic 
syndrome
[3]. It is now generally considered that  O 
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macrophages infiltrating into obese adipose tissue from 
circulation are a primary source of inflammation in 
obesity
[4] and could be involved in pathophysiology of 
insulin resistance 
[5]. Cellular and molecular 
mechanisms responsible for this macrophage 
infiltration are not clear. 
     Recently,  it  has  been  demonstrated that chemerin 
may play an important role in macrophage infiltration 
into adipose tissue
[6-8]. Chemerin is a novel adipokine 
that has been reported to serve as a chemoattractant for 
macrophages via direct interaction with its receptors 
(chemokine-like receptor-1)
[6-8]. It has been reported 
that chemerin expression in adipose tissue is increased 
in obese mice
[9]. In addition, circulating levels of 
chemerin are elevated in obese and diabetics subjects 
[10]. Furthermore, in vitro studies revealed that 
treatment with chemerin induces insulin resistance in 
human skeletal muscle cells at the levels of IRS1 
(Insulin receptor substrate 1), protein kinases B (PKB), 
and Glycogen synthase kinase 3 (GSK3) phosphor-
rylation and glucose uptake
[11]. Several studies have 
investigated the association between metabolic 
syndrome indices and chemerin
[10-12]. In these studies 
chemerin levels were positively correlated with body 
mass index, waist circumference, blood pressure, 
triglyceride (TG),  low-density lipoprotein cholesterol 
(LDL-C) levels and insulin resistance, and were 
inversely correlated with adiponectin and high-density 
lipoprotein cholesterol (HDL-C) levels. Taken 
together, these findings suggest that chemerin play an 
important role in macrophage infiltration into adipose 
tissue and may contribute to development of 
inflammation and insulin resistance.  
          Physical inactivity is a well known risk factor of 
type2 diabetes mellitus development
 [13] and aerobic 
training has been shown to reduce adiposity and insulin 
resistance in obese adults
[14]. While we know a lot 
about the mechanisms by which adiposity leads to 
insulin resistance
[15] and how exercise increases insulin 
sensitivity
[16,17], it hasn’t been yet reported about the 
exercise-induced changes in chemerin concentrations, 
which may provide a link between obesity and insulin 
resistance. Therefore, the aim of this study was to 
assess the effect of aerobic training on serum chemerin 
in relation to improvement of insulin sensitivity in 
overweight and obese men. 
METHODS AND SUBJECTS 
Twenty-one overweight and obese, middle-aged and 
sedentary men [age 44.3 (±4.1) yrs, body mass index 
(BMI)≥25 kg/m
2] were recruited to the present study. 
All participants underwent an initial eligibility 
screening in exercise physiology laboratory of Arak 
University. Eligible participants were randomized to 
exercise training (obese EX, n= 11) and control (obese 
CON, n= 10) groups. Figure 1 presents the distribution 
of study participants. The obese EX group participated 
in 12-week aerobic training program, while the obese 
CON maintained their lifestyle as usual. All subjects 
had a stable weight for at least 3 months before 
inclusion. We excluded candidates who were smoker, 
had cardiovascular diseases or any other major 
illnesses, or were taking medications that could affect 
laboratory test results. The physical activity level of 
subjects was assessed during an interview. The ethics 
committee of university  approved the experimental 
procedures and study protocols, which were fully 
explained to all subjects. A written consent form was 
signed by each subject after having read and 
understood details of the experiments. 
Dietary assessment: The subjects were instructed to 
follow their usual eating habits during the course of the 
study. Dietary intakes were registered during the 12-wk 
intervention period using 3-d dietary records. The 
participants were provided with several practice 
sessions regarding a measuring cup, spoon and ruled 
paper until they learned how to estimate the sizes of 
food items consumed. Then food records were 
analyzed using the food processor ΙΙ nutrition system-
analysis software Version 3.1 (Tehran University of 
Medical Sciences, Iran) to determine total daily caloric 
and macronutrient intake.  
Aerobic training program: Aerobic training 
supervised by an exercise physiologist was performed 
50-60 min/d, 5d/wk, for 12 weeks. At each training 
session, those in the exercise group performed warm- 
up exercises lasting 10 min, followed by a 15–50 min 
walking–running, and 10 min of relaxation exercises at 
the end of the exercise period. Exercise intensity 
progressed from 15-20 min at 60–65% of HRmax during 
the first week to 25-30 min at 60–70% of HRmax  by 
week 3, 35-40 min at 75-80% of HRmax by week 7 and  
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Subjects contacted for participation 
n = 41
Subject screened 
  n = 26 
Randomized 
n = 25
Withdrawals prior to 
randomization 
n = 1 
Week 0 
Control group 
n =12 
Week 0                               
Exercise intervention 
n = 13 
Withdrawals 
Medical reasons (n=1)          
Personal reasons (n = 1)
Withdrawals 
Personal reasons (n = 2) 
Week 12 
Completed and analyzed  
n = 11 
Week 12 
Completed and analyzed  
n = 10 
 
 
 
 
 
 
 
 
 
     
 
     
  
 
 
 
 
           
  
 
                       
    
 
 
 
 
  
                                                                               
                       
 
 
                                                                                                                                        
Fig. 1: Flow chart of subject participation. 
45-50 min at 80–85% of HRmax by week 12. Target 
heart rates were monitored using telemetry. Aerobic 
training included treadmill walking/running. Peak 
oxygen consumption (VO2 peak) was measured using a 
graded treadmill test and online computer-assisted 
open-circuit spirometry. Peak VO2 was attained when 
subjects achieved at least two of the following criteria: 
(a) a respiratory exchange ratio in excess of 1.0, (b) 
reaching  ≥85% of age-predicted HRmax, or (c) 
achieving a rating of perceived exertion (Borg Scale) 
≥17. 
Anthropometric and body composition 
measurements:  Height (m) and weight (kg) were 
measured to calculate BMI as body weight (kg)/ 
height
2 (m). Waist circumference was measured at the 
narrowest point superior to the hip using a tape ruler. 
Whole body fat mass and percent body fat was 
assessed by bioelectric impedance analysis (Body 
composition analyzer, In Body 3.0, Korea). A single-
slice computed tomography scan
  taken midway 
between L4 and L5 was performed using a Siemens 
Helicoidal Somatom Balance Scanner (Siemens,  
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Erlangen, Germany) to measure visceral and 
subcutaneous adipose tissue areas as previously 
described
[18].  
Blood pressure and blood sample analysis: Blood 
pressure was measured twice, after a 10-min rest with a 
random zero mercury sphygmomanometer, and was 
averaged. All subjects reported for blood sampling in 
the morning after an overnight fast. Post- training 
blood samples (10 ml)  from subjects in the training 
group were obtained 48 h after their last exercise 
session. After collection, blood samples were 
centrifuged (40c, 1500×g, 15min)  and plasma- and 
serum-containing tubes were stored at -70
0c until 
analysis. Plasma total cholesterol, triglyceride, and 
HDL-C were measured by enzymatic colorimetric 
methods (Pars Azmun, Tehran, Iran). LDL-C was 
calculated using the formula of Friedewald. Plasma 
glucose was determined by the glucose oxidase method 
(Pars Azmun, Tehran, Iran). Plasma insulin was 
determined by chemiluminescent immunometric assay 
(Monobind Inc, USA).  The homeostasis model 
assessment (HOMA), insulin resistance index, was 
calculated by using the formula:  
fasting glucose (mg dl -1) × fasting insulin (µU ml -1) 
× 405 -1. 
Serum chemerin concentration was determined using a 
commercially available ELISA kit (Biovendor, Czech). 
The intra-assay coefficient of variation of total 
cholesterol, TG, HDL-C, glucose, insulin, and 
chemerin were 1.1%, 1.6%, 1.9%, 1.28%, 5.3%, and 
5.1% respectively. 
Statistical analysis: Data were presented as mean ± 
SD. Normality assumption of the data was evaluated 
and was confirmed using one-sample Kolmogorov-
Smirnov test in each group. Differences between 
normal weight and obese subjects were tested using the 
independent samples t-test. Changes in dependent 
variables resulting from the exercise intervention were 
assessed by two-way time-by-group repeated measures 
analysis of variance. The assumption of homogeneity 
of variances of groups was tested and confirmed by 
Levene test for equality of variances. Pearson's 
correlation was used to analyze various variables and 
changes in variables. P<0.05 was considered 
significant. The data were analyzed using SPSS 
(version 16) software. 
RESULTS 
The clinical and metabolic characteristics of 
participants before and after 12 weeks of training are 
presented in table 1. Obese EX group completed at 
least 94% of the exercise sessions. After 12 weeks of 
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Fig. 2: Serum chemerin levels in normal weight and obese subjects before and 
after 12 weeks of aerobic training (Data are expressed as the mean ± SD).  
# significant (P<0.05) difference between before and after training.  
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aerobic training, the obese EX group had weight loss 
(P=0.02), which was accompanied with a significant 
decrease in BMI (P=0.01), waist circumference (WC) 
(P=0.009), percent body fat (P=0.03), subcutaneous fat 
(P<0.01), visceral fat (P=0.03), glucose (P=0.01), 
HOMA-IR (P=0.03), TG (P=0.05), TC (P=0.04), LDL-
C (P=0.05), and SBP (P=0.04). Besides, VO2peak 
increased significantly (P=0.03) (Table 1) and 
chemerin concentrations were decreased significantly 
in obese EX group (P=0.02) (Fig. 2). Furthermore, 
changes in chemerin concentrations after a 12-week 
training period were correlated with alterations in 
visceral fat (r = 0.65, P=0.04), subcutaneous fat (r = 
0.63, P=0.05) HOMA-IR (r = 0.67, P=0.04), glucose (r 
= 0.65, P=0.05), WC (r = 0.70, P=0.03), and VO2 peak 
(r = -0.68, P=0.04). However, no significant changes 
were observed between pre- and post testing 
measurement of variables in the obese CON group 
(P>0.05) (Table 1). 
     There were no significant differences in the amount 
of calories consumed (~35 kcal.kg
-1.d
-1) or the 
percentage of calories obtained from carbohydrate 
(~%58), protein (~%20), and fat (~%22) between 
groups during the 12-wk course of aerobic training 
(P>0.05). 
Table 1: Participant characteristics before and after 12 weeks of aerobic training 
Characteristics 
Obese CON  Obese EX 
before  after  before  after 
Anthropometric         
       Weight (kg)  96.31±6.65  96.42±6.61  97.81±5.22  94.03±4.67# 
       BMI (kg/cm
2)  29.54±1.82  29.29±1.87  29.11±1.69  28.11±1.50# 
       WC (cm)  96.88±10.43  97.55±10.45  95.00±9.84  91.88±7.75# 
       Fat (%)  35.13±2.31  35.25±2.36  35.69±2.74  33.88±2.40# 
       Visceral fat (cm
2)  148.60±20.68  149.00±20.69  149.45±19.75  146.63±19.06# 
       Subcutaneous fat (cm
2)  278.40±29.45  280.10±30.31  277±28.68  272.10±24.91# 
Insulin resistance        
        Glucose (mg dl 
-1)  98.55±12.09 96.66±10.64  99.66±12.74 94.77±9.90# 
        Insulin (µU ml 
-1)  8.03±1.28 8.17±1.04  8.23±1.69 8.15±1.47 
        HOMA-IR  1.98±0.53 1.94±0.41  2.06±0.67 1.93±0.53# 
 Lipid profile         
        TG (mg/dl)  120.22±26.84  122.55±27.87  118.33±26.88  116.11±27.94# 
        TC (mg/dl)  201.77±22.80  195.44±23.54  198.44±21.88  189.77±20.46# 
        LDL-C (mg/dl)  121.77±15.54  123.00±16.94  122.88±15.52  118.22±17.80# 
        HDL-C (mg/dl)  48.33±9.23  48.00±8.55  47.77±9.79  48.44±9.19 
Blood pressure        
        SBP (mm Hg)  130.44±7.66 129.77±7.41  131.66±6.44 129.33±7.05# 
        DBP (mm Hg)  87.77±7.69 84.22±7.62  87.22±8.59 85.11±9.22 
Vo2max (l/min)  2.17±0.45  2.22±0.51  2.13±0.40  2.25±0.43# 
Data are expressed as mean ± SD  
# significant (P<0.05) difference between before and after training  
BMI: body mass index/ WC= waist circumference/ HOMA-IR= homeostasis model assessment for insulin resistance/ 
TG: triglyceride/ TC: total cholesterol/ LDL-C: low-density lipoprotein cholesterol/ HDL-C: high-density lipoprotein cholesterol/ 
SBP: systolic blood pressure/ DBP: diastolic blood pressure/ VO2 max: maximum oxygen consumption 
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DISCUSSION 
The main finding of this study was that 12 weeks of 
aerobic training at 60-85% of HR max improved insulin 
resistance in overweight and obese subjects. The 
beneficial effect of increased physical activity on 
insulin sensitivity was accompanied by changes in 
body fat (i.e., visceral fat) and circulating chemerin 
levels. 
     Adipose  tissue  is  an  active  organ  which  secretes 
many proteins known as adipokines that are 
metabolically important
[19]. Some of these adipokines 
have important functions in incidence of insulin 
resistance and cardiovascular complications with 
obesity, especially central or visceral obesity
[20]. 
Chemerin is a recently discovered adipokine produced 
and secreted primarily by adipose tissue
[9,10]. In vitro 
studies have shown that chemerin induces insulin 
resistance at the levels of IRS1, Akt, and GSK3 
phosphorylation and glucose uptake 
[11]. Taken 
together, these results suggested that chemerin could 
play a role in the association between abdominal 
obesity and increased metabolic risk.  
     Physical inactivity is related to most components of 
the metabolic syndrome
[13]. Regular exercise results in 
reduction of risk factors of obesity, type 2 diabetes, and 
cardiovascular disease
[14,21]. The current study 
demonstrated that the obese EX group that participated 
in the 12-week exercise intervention improved body 
fatness (i.e., body weight, BMI, percent body fat, 
visceral fat, subcutaneous fat), insulin resistance (i.e., 
fasting glucose, HOMA-IR), blood lipid profile (i.e., 
TG, TC, LDL), and resting blood pressure (i.e., SBP) 
in comparison with CON group. We also found that 
aerobic fitness was significantly increased in the 
exercise group compared with the control group. Our 
observations are consistent with previous reports and 
reinforce the positive effects of exercise training on 
these important risk factors of metabolic syndrome, 
type 2 diabetes, and cardiovascular disease
[22-24]. In the 
present study, 12 weeks of aerobic training decreased 
insulin resistance by 4.7% when comparisons were 
made between pre- and post intervention levels, and 
this is in agreement with previous investigations
[23,25]. 
We observed that reduction in subjects' abdominal 
obesity who ran for ~60 minutes, 5d/wk is consistent 
with Slentz et al
[26] who reported that overweight and 
no dieting subjects performed a ~45 min activity, 
4d/wk had a marked reduction in abdominal (waist 
circumferences) obesity. These findings confirm those 
previously reported from similar well controlled trials 
[27] and suggest that exercise without caloric restriction 
for ~60 minutes at 60-85% of HRmax is associated with 
reductions in abdominal obesity. Indeed, these results 
confirm those of previous studies that found 
improvement in insulin sensitivity after aerobic 
training and abdominal obesity reduction in obese 
individuals
[27]. Several mechanisms have been 
proposed to be responsible for the increases in insulin 
sensitivity after exercise training
[16,17]. Changes in 
production of adipokines may play an important role in 
obesity-related cardiovascular complications and 
insulin resistance
[19,28] and it can help understand the 
beneficial effects of exercise.  
     The  present  study  is the first to examine the 
influence of exercise training on chemerin serum 
levels. We observed a significant decrease in chemerin 
levels in concomitant with improvements in insulin 
resistance and obesity parameters after 12 weeks of 
aerobic training. This inverse relationship is in 
accordance with the theoretical negative role of 
chemerin in regulating insulin sensitivity and metabolic 
indices. It has been shown that chemerin 
concentrations increase with adiposity
[9-12]. In 
agreement with these studies, our results showed that 
chemerin levels decreased significantly after body 
weight reduction (particularly visceral fat) in obese 
subjects. The decrease in chemerin concentrations 
indicates that changes in abdominal fat after 12 weeks 
of aerobic training may play an important role in the 
regulation of macrophage infiltration into adipose 
tissue and serum inflammatory markers (i.e., 
chemerin). Recently, surgery-induced weight loss in 
severely obese patients was demonstrated to reduce 
macrophage infiltration into adipose tissue
[29].  
     However,  the  present  paper  demonstrates  that 
weight loss obtained through aerobic training induces a 
pronounced improvement in inflammation marker 
(chemerin) and metabolic syndrome indices. Taken 
together, our finding suggests that a relatively short 
course of training is sufficient to reduce chemerin 
levels, and probably, at least in part, induces early  
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improvements in insulin resistance and other cardio 
metabolic risk factors after exercise related to the 
decrease in chemerin levels. Based on the critical 
important of inflammation in favoring cardiovascular 
and metabolic abnormalities in obesity, it could be 
suggested  that obese subjects need to participate in 
aerobic training programs that lead to loss of body 
weight  and fat reduction. 
     One limitation of this study was that we measured 
only one of the chemokines that are known to regulate 
inflammatory process. Clearly, other chemokines (e.g., 
monocyte chemoattractant protein-1) that we did not 
measure are also involved in the regulation of 
inflammation, and insulin resistance.   
CONCLUSION 
A 12-week aerobic training program decreased insulin 
resistance and abdominal obesity, and chemerin 
concentrations in overweight and obese subjects. These 
findings suggest that exercise-induced changes in 
chemerin levels may be associated with the beneficial 
effects of exercise. Further studies are needed to 
elucidate the mechanisms by which exercise affects 
chemerin and metabolic syndrome. 
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